MedPath

A Study on ayurveda drugs Shashanklekhadi Churna and Edgajadi Lepa in the treatment of Skin disease

Not yet recruiting
Conditions
Psoriasis, unspecified. Ayurveda Condition: Mandal Kushtha ,
Registration Number
CTRI/2022/01/039115
Lead Sponsor
Madan Mohan Malviya Govt Ayurved College Udaipur
Brief Summary

This study is about evaluating the efficacy of Shashankhlekhadi Churna & Edgajadi Lepa in the management of Mandal kushtha w.s.r. to Psoriasis. there will be 3 groups in group A : 10 patients will be treated for Shashankhlekhadi Churna orally 3gm with til tail. In Group B : 10 patients will be treated with Edgajadi Lepa 10gm topically with Cow urine. In group C : 10 Patients will be  treated with both Shashankhlekhadi Churna 3 gm orally & Edgajadi Lepa 10gm topically .

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria
    1. Patients willing for trial. 2. The patients who ages in between 20.
  • 70 years were selected. 3. The patients having clinical signs and symptoms of Mandal Kushtha (Psoriasis). 4. The patients having complaints less than 3 years duration.
Exclusion Criteria
  • Patients below the age of 20 years and above 70 years.
  • Patients with illness >3 years.
  • Patients with long term Steroid and cytotoxic treatment taking more than 3 years.
  • Patients with evidence of any malignancy.
  • Any drug addiction.
  • Pregnant and lactating women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in sign & symptoms2 months
Secondary Outcome Measures
NameTimeMethod
Efficacy of treatment2 months

Trial Locations

Locations (1)

Rajvaidya Premshankar Sharma Ayurved Chikitsalaya Ambamata Udaipur

🇮🇳

Udaipur, RAJASTHAN, India

Rajvaidya Premshankar Sharma Ayurved Chikitsalaya Ambamata Udaipur
🇮🇳Udaipur, RAJASTHAN, India
DR INDUMATI SHARMA
Principal investigator
7976972310
drindusharma4@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.